title: Computational modeling to predict the functions and impact of drug transporters.
abstract: Transport proteins are important mediators of cellular drug influx and efflux and play crucial roles in drug distribution, disposition and clearance. Drug-drug interactions have increasingly been found to occur at the transporter level and, hence, computational tools for studying drug-transporter interactions have gained in interest. In this short review, we present the most important transport proteins for drug influx and efflux. Computational tools for predicting and understanding the substrate and inhibitor interactions with these membrane-bound proteins are discussed. We have primarily focused on ligand-based and structure-based modeling, for which the state-of-the-art and future challenges are also discussed.
authors.affiliation: Department of Pharmacy, Uppsala University, Box 580, SE-751 23, Uppsala, Sweden. par.matsson@farmaci.uu.se.|Uppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP) - a node of the Chemical Biology Consortium Sweden, Uppsala, Sweden. par.matsson@farmaci.uu.se.
authors.forename: Pär
authors.initials: P
authors.lastname: Matsson
authors.affiliation: Department of Pharmacy, Uppsala University, Box 580, SE-751 23, Uppsala, Sweden. christel.bergstrom@farmaci.uu.se.|Uppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP) - a node of the Chemical Biology Consortium Sweden, Uppsala, Sweden. christel.bergstrom@farmaci.uu.se.
authors.forename: Christel A S
authors.initials: CA
authors.lastname: Bergström
keywords: Carrier-mediated transport; Drug transport; Ligand-based modeling; Membrane transporter; Structure-activity relationship; Structure-based modeling
references.citation: AAPS J. 2013 Oct;15(4):1128-40
references.pmid: 23982336
references.citation: Mol Pharm. 2013 Aug 5;10 (8):3152-63
references.pmid: 23822632
references.citation: Pharm Res. 2009 Aug;26(8):1816-31
references.pmid: 19421845
references.citation: J Chem Inf Model. 2014 Jan 27;54(1):218-29
references.pmid: 24050383
references.citation: Nat Rev Drug Discov. 2010 Mar;9(3):215-36
references.pmid: 20190787
references.citation: Clin Pharmacol Ther. 2013 Jul;94(1):52-63
references.pmid: 23588305
references.citation: J Med Chem. 2013 Feb 14;56(3):781-95
references.pmid: 23241029
references.citation: Xenobiotica. 2014 Jul;44(7):657-65
references.pmid: 24417751
references.citation: Pharm Res. 2013 Apr;30(4):996-1007
references.pmid: 23269503
references.citation: J Biol Chem. 2008 Mar 28;283(13):8654-63
references.pmid: 18174163
references.citation: Curr Pharm Des. 2004;10(12):1295-312
references.pmid: 15134482
references.citation: J Pharm Sci. 2004 Apr;93(4):957-68
references.pmid: 14999732
references.citation: Curr Top Med Chem. 2013;13(7):843-56
references.pmid: 23578028
references.citation: Mol Pharmacol. 2013 Jun;83(6):1257-67
references.pmid: 23571415
references.citation: J Chem Inf Model. 2012 Sep 24;52(9):2462-70
references.pmid: 22946765
references.citation: Ann Neurol. 2006 Nov;60(5):489-98
references.pmid: 17048260
references.citation: AAPS J. 2012 Dec;14(4):883-94
references.pmid: 22961390
references.citation: Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13386-91
references.pmid: 23901103
references.citation: Clin Pharmacol Ther. 2013 Jul;94(1):19-23
references.pmid: 23778706
references.citation: Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15810-5
references.pmid: 21885739
references.citation: Protein Sci. 2010 Mar;19(3):412-28
references.pmid: 20052679
references.citation: Toxicol Sci. 2013 Dec;136(2):328-43
references.pmid: 24014644
references.citation: Mol Pharm. 2013 Mar 4;10 (3):1008-19
references.pmid: 23339484
references.citation: Adv Drug Deliv Rev. 2015 Jun 23;86:17-26
references.pmid: 25769815
references.citation: Eur J Pharm Sci. 2009 Feb 15;36(2-3):254-64
references.pmid: 18955135
references.citation: Mol Pharm. 2009 Nov-Dec;6(6):1631-43
references.pmid: 19874004
references.citation: J Med Chem. 2008 Jun 12;51(11):3275-87
references.pmid: 18457386
references.citation: J Med Chem. 2011 Mar 24;54(6):1740-51
references.pmid: 21341745
references.citation: Pharm Res. 2012 Feb;29(2):411-26
references.pmid: 21861202
references.citation: Curr Pharm Des. 2011;17(26):2762-70
references.pmid: 21827407
references.citation: Mol Pharmacol. 2005 Apr;67(4):1067-77
references.pmid: 15630081
references.citation: Nature. 2014 Jun 5;510(7503):121-5
references.pmid: 24847886
references.citation: J Chem Inf Model. 2013 Jul 22;53(7):1747-60
references.pmid: 23802684
references.citation: Mol Aspects Med. 2013 Apr-Jun;34(2-3):95-107
references.pmid: 23506860
references.citation: PLoS Comput Biol. 2011 Jun;7(6):e1002083
references.pmid: 21731480
references.citation: Mol Pharm. 2013 Dec 2;10 (12 ):4443-51
references.pmid: 24102095
references.citation: Mol Pharm. 2011 Aug 1;8(4):1332-41
references.pmid: 21707071
references.citation: J Med Chem. 2011 Jul 14;54(13):4548-58
references.pmid: 21599003
references.citation: Science. 2009 Mar 27;323(5922):1718-22
references.pmid: 19325113
references.citation: J Pharmacol Exp Ther. 2007 Oct;323(1):19-30
references.pmid: 17616561
references.citation: Nat Struct Biol. 2000 Nov;7 Suppl:986-90
references.pmid: 11104007
references.citation: J Comput Aided Mol Des. 2013 Dec;27(12):1067-73
references.pmid: 24322389
references.citation: Clin Pharmacokinet. 2014 Aug;53(8):659-78
references.pmid: 25056496
references.citation: J Med Chem. 2008 Oct 9;51(19):5932-42
references.pmid: 18788725